4/24
04:07 pm
kpti
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
Neutral
Report
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting [Yahoo! Finance]
4/24
04:01 pm
kpti
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
Neutral
Report
Karyopharm Announces Presentations in Endometrial Cancer and Myelofibrosis at the 2024 American Society of Clinical Oncology Annual Meeting
4/24
09:28 am
kpti
INESSS Recommendation to Deny Reimbursement for Multiple Myeloma Treatment is a Global Outlier [Yahoo! Finance]
Low
Report
INESSS Recommendation to Deny Reimbursement for Multiple Myeloma Treatment is a Global Outlier [Yahoo! Finance]
4/3
11:20 am
kpti
Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care [Yahoo! Finance]
Medium
Report
Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care [Yahoo! Finance]
4/1
04:05 pm
kpti
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/13
04:55 pm
kpti
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor) [Yahoo! Finance]
Medium
Report
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor) [Yahoo! Finance]
3/13
04:35 pm
kpti
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)
Medium
Report
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO® (selinexor)
3/6
04:13 pm
kpti
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences [Yahoo! Finance]
High
Report
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences [Yahoo! Finance]
3/6
04:05 pm
kpti
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
High
Report
Karyopharm to Participate at Barclays 26th Annual Global Healthcare and Leerink Partners Global Biopharma Conferences
3/5
12:04 am
kpti
Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ... [Yahoo! Finance]
Medium
Report
Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ... [Yahoo! Finance]
3/1
04:05 pm
kpti
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/1
08:14 am
kpti
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.
2/29
06:23 pm
kpti
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Karyopharm Therapeutics (KPTI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/29
07:42 am
kpti
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]
High
Report
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]
2/29
07:30 am
kpti
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
High
Report
Karyopharm Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
2/22
07:03 am
kpti
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 [Yahoo! Finance]
Medium
Report
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 [Yahoo! Finance]
2/22
07:00 am
kpti
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
Medium
Report
Karyopharm to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024
2/7
06:59 am
kpti
Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though investors from three years ago are still down 90% [Yahoo! Finance]
Medium
Report
Karyopharm Therapeutics (NASDAQ:KPTI) adds US$104m to market cap in the past 7 days, though investors from three years ago are still down 90% [Yahoo! Finance]
2/1
04:05 pm
kpti
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
High
Report
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)